We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Predictors of short-term LAMA ineffectiveness in treatment naïve patients with moderate to severe COPD.
- Authors
Fijačko, Vladimir; Labor, Marina; Fijačko, Mirjana; Škrinjarić-Cincar, Sanda; Labor, Slavica; Dumbović Dubravčić, Iva; Bačun, Tatjana; Včev, Aleksandar; Popović-Grle, Sanja; Plavec, Davor
- Abstract
Background: No specific (only subgroup) recommendations for the use of long-acting muscarinic antagonists in chronic obstructive pulmonary disease (COPD) exist. The aim of this exploratory hypothesis generating study was to assess whether different phenotypic/endotypic characteristics could be determinants of the short-term ineffectiveness of the initial tiotropium bromide monotherapy in treatment naïve moderate to severe COPD patients.Methods: A total of 51 consecutively recruited COPD patients were followed for 3 months after the initial evaluation and prescribed initial treatment (tiotropium). Short-term treatment ineffectiveness was assessed as a composite measure comprising COPD exacerbations, need for additional treatment, and no improvement in functional parameters, e.g. 6‑min walking test (6MWT), body-mass index, airflow obstruction, dyspnea, and exercise (BODE) index and forced expiratory volume in 1 s (FEV1), and as single components.Results: Treatment ineffectiveness was significantly associated with baseline hemoglobin level, COPD assessment test (CAT) score, modified Medical Research Council (mMRC) scale and BODE index (<italic>p</italic> = 0.002). Incident exacerbation during the follow-up was associated with baseline bronchoalveolar lavage fluid (BALF) alpha-amylase level and CAT score (<italic>p</italic> < 0.001), and change in treatment with leukocyte count, 6MWT desaturation and fatigue (<italic>p</italic> < 0.001). No improvement in 6MWT was associated with baseline CAT score, body mass index, mMRC, fatigue, 6MWT and BODE index (<italic>p</italic> = 0.002). No improvement in BODE index was associated with leukocyte count, serum interleukin 8 (IL-8) and BALF albumin levels (<italic>p</italic> < 0.001); and no improvement in FEV1 with CAT score, baseline vital capacity and BALF tumor necrosis factor alpha (TNF-alpha) level (<italic>p</italic> < 0.001).Conclusion: Our results suggest that there is a possibility to identify predictors of short-term tiotropium ineffectiveness in patients with moderate to severe COPD.
- Subjects
MUSCARINIC antagonists; OBSTRUCTIVE lung diseases; PARASYMPATHOMIMETIC agents; LEUKOCYTE count; BODY mass index
- Publication
Wiener Klinische Wochenschrift, 2018, Vol 130, Issue 7/8, p247
- ISSN
0043-5325
- Publication type
Article
- DOI
10.1007/s00508-017-1307-7